无功能垂体腺瘤患者垂体功能减退的临床特征与术后恢复
回顾性分析2016年1月至12月北京协和医院164例无功能垂体腺瘤手术患者,80.4%存在垂体前叶功能减退,48.4%性腺功能减退,36.5%甲状腺功能减退,27.4% IGF-1/GH轴功能减退;肿瘤体积3105.1 mm³、直径23.5 mm为预测垂体功能减退的切点值。
要点
- 164例NFPA中80.4%存在垂体前叶功能减退,性腺轴受累最常见(48.4%)
- 术后激素恢复率:LH 80.9%、FSH 60%、T4 85%、FT4 87.8%、TSH 100.0%、IGF-1 77.8%
- 肿瘤体积3105.1 mm³、最大径23.5 mm为预测垂体功能减退的切点值
核心结论
- 无功能垂体腺瘤对性腺激素、IGF-1/GH及甲状腺激素有显著影响,可导致单一或多重垂体靶腺激素水平下降。
- 肿瘤大小与垂体功能减退的发生率和程度呈正相关。
- 无功能垂体腺瘤所致垂体功能减退在手术治疗后显著恢复。
研究设计与样本
- 回顾性研究,纳入2016年1月至2016年12月在北京协和医院接受手术治疗的164例无功能垂体腺瘤患者。
- 收集术前、术后及长期随访(21.1 ± 3.3个月)的人口学、影像学及内分泌资料。
- 采用配对样本及独立样本t检验分析激素水平差异,采用受试者工作特征曲线计算肿瘤大小和体积预测垂体功能减退的切点值。
主要发现
- 80.4%(132/164)患者存在垂体前叶功能减退,48.4%患者存在性腺功能减退。
- 36.5%患者存在甲状腺功能减退;27.4%患者存在胰岛素样生长因子1(IGF-1)/生长激素(GH)轴功能减退。
- 巨大腺瘤组(n=43)术前游离甲状腺素、甲状腺素、GH、IGF-1、促卵泡激素及促黄体生成素水平均显著低于大腺瘤组(n=121)。
- 肿瘤体积预测垂体功能减退的切点值为3105.1 mm³,肿瘤直径预测切点值为23.5 mm。
关键数值与推荐
- 促黄体生成素恢复率为80.9%,促卵泡激素恢复率为60%。
- 甲状腺素恢复率为85%,游离甲状腺素恢复率为87.8%,促甲状腺激素恢复率为100.0%。
- IGF-1恢复率为77.8%。
- 肿瘤体积预测垂体功能减退切点值为3105.1 mm³,肿瘤直径预测切点值为23.5 mm。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the clinical characteristics of hypopituitarism and its reversibility after surgery for nonfunctional pituitary adenoma (NFPA); analyze the correlation between tumor size and hypopituitarism incidence; and predict hypopituitarism by tumor volume and maximum diameter. METHODS: We retrospectively reviewed 164 patients with NFPA who underwent surgical treatment at Peking Union Medical College Hospital from January 2016 to December 2016. Demographic, imaging, and endocrine data were collected during preoperative, postoperative, and long-term follow-up (21.1 ± 3.3 months) periods. Differences in hormone levels were analyzed by paired and independent samples t-tests. The cut-off values of tumor size and volume to predict hypopituitarism were calculated by receiver operating characteristic curves. RESULTS: In total, 80.4% (132/164) of patients had anterior pituitary hypofunction and 48.4% patients had hypogonadism; the recovery rate of luteinizing hormone was 80.9%, and follicular-stimulating hormone was 60%. In total, 36.5% of patients had hypothyroidism; the recovery rate of thyroxine was 85%, free thyroxine was 87.8%, and thyroid-stimulating hormone was 100.0%. Finally, 27.4% of patients had insulin-like growth factor 1 (IGF-1)/growth hormone (GH) hypofunction, and the recovery rate of IGF-1 was 77.8%. The preoperative free thyroxine, thyroxine, GH, IGF-1, follicular-stimulating hormone, and luteinizing hormone levels were significantly lower in the giant adenoma group (n = 43) than in the large adenoma group (n = 121). The hypopituitarism predictive cut-off value of tumor volume was 3105.1 mm3 and that of tumor diameter was 23.5 mm. CONCLUSIONS: NFPA has a significant influence on gonadal hormone, IGF-1/GH, and thyroid hormone. NFPA can cause single- or multiple-hormone reduction in each pituitary target gland. Tumor size is positively correlated with the incidence and degree of hypopituitarism. NFPA-induced hypopituitarism is significantly recovered after surgical treatment.
引用
- Zhang R, Wang Z, Gao L, et al. Clinical Characteristics and Postoperative Recovery of Hypopituitarism in Patients with Nonfunctional Pituitary Adenoma. World Neurosurg. 2019. PMID: 30880207. doi:10.1016/j.wneu.2019.03.062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。